-
Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum
de Leeuw, D. M., Trieu, C., Vromen, E. M., Blujdea, E. R., Verberk, I. M. W., Duits, F. H., Teunissen, C. E., Pijnenburg, Y. A. L., van der Flier, W. M., van Harten, A. C., Visser, P. J. & Tijms, B. M., 1 Jul 2025, In: JAMA Network Open. 8, 7, p. e2519919Research output: Contribution to journal › Article* › Academic › peer-review
-
Needs expressed by people with subjective cognitive decline during amyloid PET disclosure consultations: An observational study
de Rijke, T. J., Hendriksen, H. M. A., Fruijtier, A. D., van Harten, A. C., van Leeuwenstijn-Koopman, M. S. S. A., van de Giessen, E. M., Trieu, C., Visser, D., Street, R. L., van der Flier, W. M., Smets, E. M. A. & Visser, L. N. C., 1 May 2025, In: Patient education and counseling. 134, 108668.Research output: Contribution to journal › Article* › Academic › peer-review
-
Longitudinal associations between amyloid and symptoms of depression and anxiety in subjective cognitive decline: the impact of personality characteristics
Trieu, C., van Leeuwenstijn, M. S. S. A., Schlüter, L.-M., Ebenau, J. L., Verberk, I. M. W., Sikkes, S. A. M., Verfaillie, S. C. J., van de Giessen, E., Teunissen, C. E., van der Flier, W. M. & van Harten, A. C., 2025, In: Frontiers in psychiatry. 16, 1572174.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications